Pregnancy and infant outcomes in the clinical trials of a human papillomavirus type 6/11/16/18 vaccine: A combined analysis of five randomized controlled trials

Obstetrics and Gynecology

Volumn 114, Issue 6, 2009, Pages 1179-1188

  Garland, Suzanne M ^a   Ault, Kevin A ^b   Gall, Stanley A ^b   Paavonen, Jorma ^b   Sings, Heather L ^b   Ciprero, Karen L ^b   Saah, Alfred ^b   Marino, Deborah ^b   Ryan, Desmond ^b   Radley, David ^b   Zhou, Haiping ^b   Haupt, Richard M ^b   Garner, Elizabeth I O ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE; HUMAN PAPILLOMAVIRUS VACCINE L1, TYPE 6,11,16,18;

ADRENAL CANCER; ADULT; ALPHA THALASSEMIA; ARTICLE; BIRTH CONTROL; BRANCHIOGENIC CYST; BREAST FEEDING; BRONCHIOLITIS; BRONCHOPNEUMONIA; CEPHALOPELVIC DISPROPORTION; CHILL; CHOANA ATRESIA; CLEFT LIP; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; CONGENITAL MALFORMATION; CROUZON SYNDROME; CRYPTORCHISM; DRUG SAFETY; DRUG TOLERABILITY; EAR MALFORMATION; ECTOPIC PREGNANCY; FATALITY; FETUS OUTCOME; FETUS WASTAGE; FEVER; GASTROSCHISIS; HEADACHE; HEART MURMUR; HEART VENTRICLE SEPTUM DEFECT; HEMATEMESIS; HIP DYSPLASIA; HIRSCHSPRUNG DISEASE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; HYDRONEPHROSIS; HYPERBILIRUBINEMIA; HYPERTENSIVE CRISIS; HYPOACUSIS; IMMINENT ABORTION; INFANT DISEASE; INJECTION SITE CONTUSION; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE PRURITUS; INJECTION SITE SWELLING; KIDNEY AGENESIS; LIMB MALFORMATION; LIVE BIRTH; LUNG VEIN DRAINAGE ANOMALY; MENINGITIS; MENINGOCELE; NAUSEA; NEWBORN JAUNDICE; PATENT DUCTUS ARTERIOSUS; PERSISTENT PULMONARY HYPERTENSION; PNEUMONIA; POLYDACTYLY; POSTMARKETING SURVEILLANCE; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PREGNANCY TEST; PREMATURE LABOR; PRIORITY JOURNAL; PROPHYLAXIS; PTOSIS; PULMONARY VALVE ATRESIA; PYLORUS STENOSIS; SEPSIS; SPONTANEOUS ABORTION; TRISOMY 21; UTERINE CERVIX CANCER; ADOLESCENT; CHEMICALLY INDUCED DISORDER; FEMALE; LACTATION; MIDDLE AGED; NEWBORN; NEWBORN DISEASE; PHASE 3 CLINICAL TRIAL; PREGNANCY; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; CLINICAL TRIALS, PHASE III AS TOPIC; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; LACTATION; MIDDLE AGED; PAPILLOMAVIRUS VACCINES; PREGNANCY; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIALS AS TOPIC; YOUNG ADULT;

EID: 73349128149     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181c2ca21     Document Type: Article

References (22)

1. Barr E, Sings HL. Prophylactic HPV vaccines: new interventions for cancer control. Vaccine 2008;26:6244-6257
2. Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007;356:1928-1943 (Pubitemid 46740303)
3. The FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007;356:1915-1927
4. Adams M, Jasani B, Fiander A. Prophylactic HPV vaccination for women over 18 years of age. Vaccine 2009;27:3391-3394
5. Block SL, Nolan T, Sattler C, Barr E, Giacoletti KE, Marchant CD, et al. Comparison of the immunogenicity and reactoge-nicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women. Pediatrics 2006;118:2135-2145
6. Reisinger KS, Block SL, Lazcano-Ponce E, Samakoses R, Esser MT, Erick J, et al. Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 viruslike particle vaccine in preadolescents and adolescents: a randomized controlled trial. Ped Infect Dis Journal 2007;26:201-209
7. Munoz N, Manalastas R, Pitisuttihum P, Tresukosol D, Monsonego J, Ault K, et al. Safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women between 24 and 45 years of age: a randomized, double-blind trial. Lancet 2009;373:1921-1922.
8. Villa LL, Costa RLR, Petta CA, Andrade RP, Ault KA, Giuliano AR, et al. Prophylactic quadrivalent human papillo-mavirus (types 6, 11, 16 and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncology 2005;6:271-278
9. Miettinen O, Nurminen M. Comparative analysis of two rates. Stat Med 1985;4:213-226
10. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481
11. US Food and Drug Administration. Reviewer guidance: evaluating the risks of drug exposure in human pregnancies. Available at: http://www.fda.gov/cder/ guidance/6777fnl.pdf. Retrieved February 18, 2009.
12. EUROCAT. European surveillance of congenital anomalies. Available at: http://www.eurocat.ulster.ac.uk/index. html. Retrieved February 3, 2009.
13. Wang X, Chen C, Wang L, Chen D, Guang W, French J. Conception, early pregnancy loss and time to clinical pregnancy: a population-based prospective study. Fertil Steril 2003; 79:577-584
14. Centers for Disease Control and Prevention. Guidelines for vaccinating pregnant women. Available at: http://www.cdc.gov/ vaccines/pubs/preg-guide.htm. Retrieved December 5, 2008.
15. Harjulehto-Mervaala T, Hovi T, Aro T, Saxen H, Hiilesmaa VK. Oral poliovirus vaccination and pregnancy complications. Acta Obstet Gynecol Scand 1995;74:262-265
16. Harjulehto-Mervaala T, Aro T, Hiilesmaa VK, Saxen H, Hovi T, Saxen L. Oral polio vaccination during pregnancy: no increase in the occurrence of congenital malformations. Am J Epidemiol 1993;138:407-414
17. Munoz FM, Englund JA. A step ahead. Infant protection through maternal immunization. Pediatr Clin North Am 2000; 47:449-463
18. Demicheli V, Barale A, Rivetti A. Vaccines for women to prevent neonatal tetanus. The Cochrane Database of Systematic Reviews, 2005, Issue 19. Art. No.: CD002959.
19. Healy CM, Baker CJ. Prospects for prevention of childhood infections by maternal immunization. Curr Opin Infect Dis 2006;19:271-276
20. Healy CM, Baker CJ. Maternal immunization. Pediatr Infect Dis J 2007;26:945-948
21. Merck & Co. Gardasil prescribing information. Available at: http://www.merck.com/ product/usa/pi circulars/g/gardasil/ gardasil pi.pdf. Retrieved December 8, 2008.
22. Dana A, Buchanan KM, Goss MA, Seminack MM, Shields KE, Korn S, et al. Pregnancy outcomes from the Pregnancy Registry of a Human Papillomavirus Type 6/11/16/18 Vaccine. Obstet Gynecol 2009;114:1170-1178